Annual Report

Overview

The report presents Sun Pharma's FY2024-25 performance across global pharmaceutical operations, with sustainability embedded in energy efficiency, renewable energy, water conservation, waste management and workforce safety. The company reports renewable energy at 49.77% of its energy mix, a 31.70% reduction in water consumption versus the 2020 baseline, and ₹ 508.34 million spent on CSR initiatives reaching over 1 million lives. DNV provided reasonable assurance over nine BRSR Core ESG attributes.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2024-2025
Period: 1 April 2024 – 31 March 2025
Language: English
Pages
File size
Restatement: Disclosed

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Materiality

Assessment
Basis

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services